Corcept Therapeutics Incorporated CORT

116.10 (2.41) (2.03%) as of 25 Sep
Market cap
$12.9B
P/E
223×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
105.44 16.05 20.55 14.58 28.43 22.76 21.23 23.46 37.33 37.02
P/S ratio
10.01 12.94 6.13 4.51 8.53 6.26 5.36 5.19 7.71 4.75
P/FCF ratio
44.72 34.03 13.36 10.25 20.03 13.68 17.96 19.78 26.52 25.49
P/Operating CF
178.11 82.76 71.61 28.56 86.09 46.33 64.51 452.52 86.61 94.01
P/B ratio
19.67 10.78 5.59 3.73 5.77 6.09 4.29 4.94 7.65 5.58
Price to Tangible BV
19.67 10.78 5.59 3.73 5.77 6.09 4.29 4.94 7.65 5.58
EV/Sales
9.60 12.47 5.37 3.63 7.29 5.65 4.29 4.43 7.15 4.27
EV/EBITDA
75.89 37.46 15.32 9.77 19.79 15.54 14.68 21.24 37.89 78.09
EV/Operating CF
42.45 32.57 11.66 8.16 16.98 12.31 14.33 16.85 24.33 22.87
EV/FCF
42.90 32.79 11.69 8.23 17.12 12.35 14.38 16.87 24.60 22.90
Quick Ratio
2.24 3.95 6.31 7.62 9.83 5.28 6.38 3.92 3.11 2.60
Current Ratio
2.40 4.20 6.66 7.91 10.08 5.60 6.89 4.39 3.35 2.92
Net Debt/EBITDA
(3.58) (1.68) (2.35) (2.39) (3.36) (1.68) (3.67) (3.66) (2.96) (8.83)
Debt/Assets
21.33% 0.00% 0.00% 0.84% 0.45% 0.12% 0.20% 0.00% 0.73% 0.60%
Debt/Equity
0.35 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.01 0.01
Asset Turnover
1.35 1.10 0.94 0.85 0.72 0.74 0.80 0.80 0.92 0.91
Operating CF/Net income
2.26 0.47 1.53 1.45 1.43 1.49 1.19 1.20 1.42 1.45
Capex/Depreciation
(1.80) (3.49) 0.20 (0.50) (0.55) (0.05) (0.09) 0.02 0.23 0.07
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
27.19% 111.15% 32.31% 29.11% 23.70% 25.03% 23.08% 20.92% 23.56% 14.79%
ROA
13.49% 89.27% 28.34% 26.02% 21.55% 22.60% 20.11% 17.51% 19.11% 11.71%
ROIC
141.16% 32.32% 80.92% 70.69% 94.05% 50.92% 98.71% 48.42% 28.31% 9.98%
Return on Tangible Assets
21.13% 135.73% 37.35% 34.94% 24.50% 51.16% 23.70% 29.77% 41.90% 30.56%
Average Days of Receivables
44.26 64.64 25.55 23.73 27.02 27.55 28.21 31.12 29.19 28.66
Research and Development Expense of Revenue
29.32% 25.36% 29.95% 29.04% 32.43% 31.11% 32.60% 38.22% 36.57% 33.48%
Selling, General and Administrative Expense of Revenue
55.63% 39.21% 32.35% 32.75% 29.76% 33.43% 38.04% 38.20% 41.53% 58.93%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
8.68% 8.39% 9.45% 9.56% 9.48% 11.73% 10.56% 10.15% 9.09% 11.10%
Graham Net Nets
0.05 0.05 0.13 0.19 0.14 0.10 0.19 0.14 0.06 0.08
Graham Number
0.77 6.54 5.91 7.79 9.69 7.98 10.02 10.65 14.14 11.49
Earnings Yield
0.95% 6.23% 4.87% 6.86% 3.52% 4.39% 4.71% 4.26% 2.68% 2.70%
Free Cash Flow Yield
2.24% 2.94% 7.49% 9.76% 4.99% 7.31% 5.57% 5.06% 3.77% 3.92%
Revenue per Share
0.74 1.40 2.18 2.68 3.07 3.16 3.76 4.66 6.54 7.33
Operating CF per Share
0.17 0.54 1.00 1.19 1.32 1.45 1.13 1.22 1.92 1.37
Capex per Share
0.00 0.00 0.00 (0.01) (0.01) 0.00 0.00 0.00 (0.02) 0.00
Free Cash Flow per Share
0.16 0.53 1.00 1.18 1.31 1.45 1.12 1.22 1.90 1.37
Cash per Share
0.47 0.78 1.79 2.41 3.82 1.93 4.04 3.56 3.71 3.58
Shareholders Equity per Share
0.37 1.68 2.39 3.25 4.53 3.25 4.70 4.89 6.58 6.24
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.37 1.68 2.39 3.25 4.53 3.25 4.70 4.89 6.58 6.24
Free Cash Flow
18.20 60.52 115.37 135.03 150.73 167.42 119.91 126.54 196.12 141.79
Working Capital
38.32 94.62 201.25 268.52 431.01 218.92 426.76 354.13 330.83 319.38
Capital Expenditures
(0.19) (0.42) (0.30) (1.09) (1.24) (0.47) (0.41) (0.14) (2.17) (0.21)
Net Current Asset Value
38.32 94.62 201.01 266.23 430.11 218.51 417.67 343.82 310.64 296.62
EV/EBIT
76.69 37.55 15.06 9.96 20.13 16.61 15.31 19.90 35.23 72.49
Capex to Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Profit Margin
10.01% 81.11% 30.01% 30.73% 29.96% 30.74% 25.20% 21.87% 20.70% 12.89%
Price to Operating Income
79.95 38.96 17.22 12.40 23.55 18.40 19.12 23.32 37.98 80.68
Other line items
Depreciation/Fixed assets
0.53 0.23 (2.27) 2.07 1.34 8.54 7.63 (34.70) (3.57) (1.70)
Cash ROIC
16.90% 21.60% 23.83% 20.76% 15.55% 27.82% 12.81% 14.46% 18.30% 13.67%
Accounts Receivable Turnover
10.11 8.37 10.98 16.34 15.34 13.60 13.70 13.37 14.20 13.39
Accounts Payable Turnover
1.14 0.65 0.62 0.70 0.62 0.60 0.57 0.44 0.66 0.47
Inventory Turnover
1.03 1.03 1.12 1.08 1.08 1.07 0.97 0.94 1.08 1.03
Average Days of Payables
406.15 881.07 578.54 499.82 690.11 477.45 811.74 979.72 515.74 1,137.56
Days of Inventory on Hand
413.06 469.96 331.19 359.69 321.06 344.75 413.46 435.34 416.32 361.93
Average Receivables
8.04 19.03 22.89 18.76 23.06 26.91 29.34 36.09 47.55 56.88
Average Payables
1.81 5.43 8.42 7.90 9.05 8.73 9.44 14.69 16.39 27.91
Average Inventory
2.01 3.45 4.65 5.08 5.17 4.95 5.54 6.92 10.07 12.64
Average Assets
60.33 144.65 266.12 362.00 492.02 497.74 503.59 602.47 731.04 838.60
Average Common Equity
29.94 116.17 233.43 323.53 447.26 449.57 438.82 504.27 593.15 663.70

Fold the line items

Columns are period end dates